BJDX - Company ID 0001704287
The table below shows Bluejay Diagnostics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $5.16M | $4.30M | $2.21M | $10.11M | $19.05M |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | $84.76K |
| Total current assets | $5.46M | $4.90M | $3.22M | $11.79M | $20.66M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $1.53M | $1.51M | $1.29M | $1.23M | $337.37K |
| Goodwill | - | - | - | - | - |
| Total assets | $7.12M | $6.66M | $4.87M | $13.52M | $21.02M |
| Accounts payable | $214.25K | $145.12K | $491.47K | $635.82K | $295.78K |
| Total current liabilities | $1.12M | $810.37K | $1.77M | $1.64M | - |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $1.14M | $927.92K | $1.97M | $1.98M | $637.16K |
| Retained earnings | -$41.52M | -$34.67M | -$26.95M | -$17.00M | -$7.69M |
| Total equity | $5.98M | $5.73M | $2.89M | $11.54M | $20.38M |